Herbas VPB

Print
EN | LT
LT - USE OF LOW DOSES OF OLIGONUCLEOTIDES ANTISENSE TO TGF-BETA1 GENES IN THE TREATMENT OF TUMORS
EN - USE OF LOW DOSES OF OLIGONUCLEOTIDES ANTISENSE TO TGF-BETA1 GENES IN THE TREATMENT OF TUMORS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/7125
A61P 37/06
A61P 25/00
C12N 15/11
European patent
(11) Number of the document 2062586
(13) Kind of document T
(96) European patent application number 08173070.7
Date of filing the European patent application 2006-05-04
(97) Date of publication of the European application 2009-05-27
(45) Date of publication and mention of the grant of the patent 2017-03-15
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
680493 P 2005-05-13 US
05009802 2005-05-05 EP
Inventors
(72)
Schlingensiepen, Karl-Hermann, DE
Schlingensiepen, Reimar, DE
Grantee
(73) Autotelic LLC, 17870 Castleton Street, Suite 250, City of Industry, CA 91748, US
Title
(54) USE OF LOW DOSES OF OLIGONUCLEOTIDES ANTISENSE TO TGF-BETA1 GENES IN THE TREATMENT OF TUMORS
  USE OF LOW DOSES OF OLIGONUCLEOTIDES ANTISENSE TO TGF-BETA1 GENES IN THE TREATMENT OF TUMORS
Last update date 2021-04-30